Works matching AU Eun Kyung Cho

Results: 56
    1
    2

    Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.

    Published in:
    2018
    By:
    • Ramalingam, Suresh S.;
    • Pérol, Maurice;
    • Reck, Martin;
    • Kowalyszyn, Ruben Dario;
    • Gautschi, Oliver;
    • Kimmich, Martin;
    • Eun Kyung Cho;
    • Czyzewicz, Grzegorz;
    • Grigorescu, Alexandru;
    • Karaseva, Nina;
    • Dakhil, Shaker;
    • Pablo Lee;
    • Zimmerman, Annamaria;
    • Sashegyi, Andreas;
    • Alexandris, Ekaterine;
    • Carter, Gebra Cuyun;
    • Winfree, Katherine B.;
    • Garon, Edward B.;
    • Cho, Eun Kyung;
    • Lee, Pablo
    Publication type:
    journal article
    3

    An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.

    Published in:
    2021
    By:
    • Keunchil Park;
    • Jin-Soo Kim;
    • Joo-Hang Kim;
    • Young-Chul Kim;
    • Hoon-Gu Kim;
    • Eun Kyung Cho;
    • Jong-Youl Jin;
    • Miyoung Kim;
    • Märten, Angela;
    • Jin-Hyoung Kang;
    • Park, Keunchil;
    • Kim, Jin-Soo;
    • Kim, Joo-Hang;
    • Kim, Young-Chul;
    • Kim, Hoon-Gu;
    • Cho, Eun Kyung;
    • Jin, Jong-Youl;
    • Kim, Miyoung;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    4

    Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.

    Published in:
    Cancer Research & Treatment, 2024, v. 56, n. 1, p. 48, doi. 10.4143/crt.2023.453
    By:
    • Ki Hyeong Lee;
    • Byoung Chul Cho;
    • Myung-Ju Ahn;
    • Yun-Gyoo Lee;
    • Youngjoo Lee;
    • Jong-Seok Lee;
    • Joo-Hang Kim;
    • Young Joo Min;
    • Gyeong-Won Lee;
    • Sung Sook Lee;
    • Kyung-Hee Lee;
    • Yoon Ho Ko;
    • Byoung Yong Shim;
    • Sang-We Kim;
    • Sang Won Shin;
    • Jin-Hyuk Choi;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Keon Uk Park;
    • Jin-Soo Kim
    Publication type:
    Article
    5

    Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.

    Published in:
    Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1112, doi. 10.4143/crt.2020.245
    By:
    • Sun Min Lim;
    • Sang-We Kim;
    • Byoung Chul Cho;
    • Jin Hyung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Young-Chul Kim;
    • Jin Soo Lee;
    • Jong-Seok Lee;
    • Sung Yong Lee;
    • Keon Uk Park;
    • Ho Jung An;
    • Eun Kyung Cho;
    • Tae Won Jang;
    • Bong-Seog Kim;
    • Joo-Hang Kim;
    • Sung Sook Lee;
    • Im-II Na;
    • Seung Soo Yoo;
    • Ki Hyeong Lee
    Publication type:
    Article
    6

    Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
    By:
    • Keunchil Park;
    • Eun Kyung Cho;
    • Maximino Bello;
    • Myung-Ju Ahn;
    • Thongprasert, Sumitra;
    • Eun-Kee Song;
    • Soldatenkova, Victoria;
    • Depenbrock, Henrik;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    7

    Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results.

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 2, p. 423, doi. 10.4143/crt.2016.191
    By:
    • Yeon Hee Park;
    • Tae Yong Kim;
    • Young-Hyuck Im;
    • Keun-Seok Lee;
    • In Hae Park;
    • Joohyuk Sohn;
    • Soo-Hyeon Lee;
    • Seock-Ah Im;
    • Jee Hyun Kim;
    • Se Hyun Kim;
    • Soo Jung Lee;
    • Su-Jin Koh;
    • Ki Hyeong Lee;
    • Yoon Ji Choi;
    • Eun Kyung Cho;
    • Suee Lee;
    • Seok Yun Kang;
    • Jae Hong Seo;
    • Sung-Bae Kim;
    • Kyung Hae Jung
    Publication type:
    Article
    8
    9
    10

    East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1177, doi. 10.4143/crt.2015.401
    By:
    • Keunchil Park;
    • Joo-Hang Kim;
    • Eun Kyung Cho;
    • Jin-Hyoung Kang;
    • Jin-Yuan Shih;
    • Zimmermann, Annamaria Hayden;
    • Pablo Lee;
    • Alexandris, Ekaterine;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    11

    Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
    By:
    • Jin Hyoung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Joo-Hang Kim;
    • Sang Won Shin;
    • Xin Wang;
    • Jong Seok Kim;
    • Mauro Orlando;
    • Keunchil Park
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study.

    Published in:
    BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03620-8
    By:
    • Han, Ji-Youn;
    • Ahn, Myung-Ju;
    • Lee, Ki Hyeong;
    • Lee, Yun-Gyoo;
    • Kim, Dong-Wan;
    • Min, Young Joo;
    • Kim, Sang-We;
    • Cho, Eun Kyung;
    • Kim, Joo-Hang;
    • Lee, Gyeong-Won;
    • Lee, Sung Sook;
    • Lee, Na Mi;
    • Jang, Hyun Woo;
    • Han, Heewon;
    • Park, Hyejoo;
    • Lee, Jieon;
    • Cho, Byoung Chul
    Publication type:
    Article
    19
    20
    21
    22

    Global variation in copy number in the human genome.

    Published in:
    Nature, 2006, v. 444, n. 7118, p. 444, doi. 10.1038/nature05329
    By:
    • Redon, Richard;
    • Ishikawa, Shumpei;
    • Fitch, Karen R.;
    • Feuk, Lars;
    • Perry, George H.;
    • Andrews, T. Daniel;
    • Fiegler, Heike;
    • Shapero, Michael H.;
    • Carson, Andrew R.;
    • Wenwei Chen;
    • Eun Kyung Cho;
    • Dallaire, Stephanie;
    • Freeman, Jennifer L.;
    • González, Juan R.;
    • Gratacòs, Mònica;
    • Jing Huang;
    • Kalaitzopoulos, Dimitrios;
    • Komura, Daisuke;
    • MacDonald, Jeffrey R.;
    • Marshall, Christian R.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization S. R. Setlur et al Array-CGH in Familial and Sporadic CLL.

    Published in:
    British Journal of Haematology, 2010, v. 151, n. 4, p. 336, doi. 10.1111/j.1365-2141.2010.08341.x
    By:
    • Setlur, Sunita R.;
    • Ihm, Chunhwa;
    • Tchinda, Joelle;
    • Shams, Soheil;
    • Werner, Lillian;
    • Eun Kyung Cho;
    • Thompson, Christina;
    • Phillips, Kimberly;
    • Rassenti, Laura Z.;
    • Kipps, Thomas J.;
    • Neuberg, Donna;
    • Freedman, Arnold S.;
    • Lee, Charles;
    • Brown, Jennifer R.
    Publication type:
    Article
    32

    Generalized List Colouring of Graphs.

    Published in:
    Graphs & Combinatorics, 2021, v. 37, n. 6, p. 2121, doi. 10.1007/s00373-021-02336-3
    By:
    • Cho, Eun-Kyung;
    • Choi, Ilkyoo;
    • Jiang, Yiting;
    • Kim, Ringi;
    • Park, Boram;
    • Yan, Jiayan;
    • Zhu, Xuding
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 10, p. 1, doi. 10.1007/s00262-024-03782-7
    By:
    • Park, Changhee;
    • Suh, Koung Jin;
    • Kim, Se Hyun;
    • Lee, Kyung-Hun;
    • Im, Seock-Ah;
    • Kim, Min Hwan;
    • Sohn, Joohyuk;
    • Jeong, Jae Ho;
    • Jung, Kyung Hae;
    • Lee, Kyoung Eun;
    • Park, Yeon Hee;
    • Kim, Hee-Jun;
    • Cho, Eun Kyung;
    • Choi, In Sil;
    • Noh, Seung-Jae;
    • Shin, Inkyung;
    • Cho, Dae-Yeon;
    • Kim, Jee Hyun
    Publication type:
    Article
    47
    48
    49
    50